九典制药：累计回购约618万股

Group 1 - The company, Jiutian Pharmaceutical, announced a share buyback of approximately 6.18 million shares, accounting for 1.24% of its total share capital, with a total transaction amount of about 100 million yuan [1][1][1] - The highest transaction price during the buyback was 18.44 yuan per share, while the lowest was 14.51 yuan per share [1][1][1] - As of the report, Jiutian Pharmaceutical has a market capitalization of 9.5 billion yuan [1][1][1] Group 2 - For the first half of 2025, the revenue composition of Jiutian Pharmaceutical is as follows: 82.47% from pharmaceutical preparations, 7.65% from raw materials, 6.03% from pharmaceutical excipients, 3.16% from plant extracts and others, and 0.63% from technology transfer and services [1][1][1]